GlassScriptPhysician profile
Steven M Miller
NPI 1699850875
$5,313.23
in general payments reported to CMS, 2019-2025
39 companies · $695 in 2025
The $695 reported for 2025 was more than what 87% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $582 · 2020: $402 · 2021: $899 · 2022: $1,187 · 2023: $828 · 2024: $721 · 2025: $695.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,244.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,244.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $711.33 | 2022-2025 | Veozah, Myrbetriq |
| Abbvie INC. | $535.68 | 2019-2025 | |
| Therapeuticsmd, INC. | $369.73 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $292.30 | 2020-2025 | |
| Pfizer INC. | $282.41 | 2019-2025 | |
| Coopersurgical, INC. | $262.43 | 2019-2025 | Paragard T 380a, Paragard T 380a |
| Organon LLC | $241.17 | 2021-2025 | Nexplanon |
| Exeltis, USA INC. | $238.34 | 2021-2025 | Slynd |
| Mayne Pharma Commercial LLC | $193.56 | 2021-2023 | |
| Myovant Sciences INC. | $173.09 | 2021-2022 | |
| Sage Therapeutics, LLC | $168.33 | 2024-2025 | Zurzuvae |
| Millicent US INC | $146.31 | 2019-2025 | Intrarosa, Femring, Femlyv |
| Sumitomo Pharma America, INC. | $132.55 | 2023-2025 | Myfembree, Gemtesa |
| Avion Pharmaceuticals | $128.50 | 2019-2022 | |
| Hologic Sales and Service, LLC | $128.06 | 2020-2023 | Thinprep 2000 Processor, Aptima |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.